KMB
33
2
SE
52
2
CHRW
37
-13
EQIX
57
-3
VZ
34
-3
TMO
51
4
SWK
64
3
STX
50
-2
RIG
55
-3
ABT
62
9
AME
54
-8
AMZN
56
5
PYPL
39
-4
GPC
22
-3
CHD
58
10
NEE
47
-5
ZTS
36
7
EXPE
72
2
BAX
38
3
CA
10
-3
KMB
33
2
SE
52
2
CHRW
37
-13
EQIX
57
-3
VZ
34
-3
TMO
51
4
SWK
64
3
STX
50
-2
RIG
55
-3
ABT
62
9
AME
54
-8
AMZN
56
5
PYPL
39
-4
GPC
22
-3
CHD
58
10
NEE
47
-5
ZTS
36
7
EXPE
72
2
BAX
38
3
CA
10
-3
Financhill
Back

ALX Oncology Holdings 10K Form

Sell
30

ALXO
ALX Oncology Holdings

Last Price:
1.50
Seasonality Move:
30.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-03-18 10K ALXO/ALX Oncology Holdings Annual
2020-11-12 10Q ALXO/ALX Oncology Holdings Quarterly
2020-08-27 10Q ALXO/ALX Oncology Holdings Quarterly

Receive ALXO News And Ratings

See the #1 stock for the next 7 days that we like better than ALXO

ALXO Financial Statistics

Sales & Book Value

Annual Sales: $1.18M
Cash Flow: $-26.66M
Price / Cash Flow: 0
Annual Sales: $3.04
Price / Book: 0.48

Profitability

EPS (TTM): -3.63000
Net Income (TTM): $-171.44M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

ALX Oncology Holdings Earnings Forecast

Key ALX Oncology Holdings Financial Ratios

  • The Selling, General & Administrative Expenses for ALXO have been equal to 1,252.88% of Gross Profit Margin.
  • The Interest Expense is -0.97% of Operating Income.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

ALX Oncology Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALXO
Website: alxoncology.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ALXO Technical Analysis vs Fundamental Analysis

Sell
30
ALX Oncology Holdings (ALXO) is a Sell

Is ALX Oncology Holdings a Buy or a Sell?